Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 191 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 522 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 601 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 362 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 236 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 304 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 68.8 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 41.6 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 0.0 | BCD100427B001 | 43.9 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 0.5 | BCD100427B003 | 361 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 1.0 | BCD100427B007 | 773 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 2.0 | BCD100427B011 | 395 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 4.0 | BCD100427B015 | 380 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 8.0 | BCD100427B019 | 186 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 12.0 | BCD100427B023 | 87.5 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | C | 24.0 | BCD100427B027 | 44.7 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 402 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 354 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 377 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 252 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 318 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 62.1 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 109 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 0.5 | BCD100427B004 | 637 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 1.0 | BCD100427B008 | 382 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 2.0 | BCD100427B012 | 718 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 4.0 | BCD100427B016 | 351 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 8.0 | BCD100427B020 | 76.9 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 12.0 | BCD100427B024 | 366 | pmol/sample |
| - | PE(38:6e)/PE(38:5p) | 25OH-Chol | 24.0 | BCD100427B028 | 17.6 | pmol/sample |